JPWO2025211357A5 - - Google Patents

Info

Publication number
JPWO2025211357A5
JPWO2025211357A5 JP2025558591A JP2025558591A JPWO2025211357A5 JP WO2025211357 A5 JPWO2025211357 A5 JP WO2025211357A5 JP 2025558591 A JP2025558591 A JP 2025558591A JP 2025558591 A JP2025558591 A JP 2025558591A JP WO2025211357 A5 JPWO2025211357 A5 JP WO2025211357A5
Authority
JP
Japan
Prior art keywords
agent according
nucleic acid
acid encoding
fragment
egf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025558591A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2025211357A1 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2025/013342 external-priority patent/WO2025211357A1/ja
Publication of JPWO2025211357A1 publication Critical patent/JPWO2025211357A1/ja
Publication of JPWO2025211357A5 publication Critical patent/JPWO2025211357A5/ja
Pending legal-status Critical Current

Links

JP2025558591A 2024-04-02 2025-04-01 Pending JPWO2025211357A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2024059835 2024-04-02
PCT/JP2025/013342 WO2025211357A1 (ja) 2024-04-02 2025-04-01 糖尿病に対するｓＨＢ－ＥＧＦ強化治療

Publications (2)

Publication Number Publication Date
JPWO2025211357A1 JPWO2025211357A1 (https=) 2025-10-09
JPWO2025211357A5 true JPWO2025211357A5 (https=) 2026-03-11

Family

ID=97267051

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2025558591A Pending JPWO2025211357A1 (https=) 2024-04-02 2025-04-01

Country Status (3)

Country Link
JP (1) JPWO2025211357A1 (https=)
TW (1) TW202602484A (https=)
WO (1) WO2025211357A1 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1949907B1 (en) * 2005-09-28 2014-07-02 Kagoshima University Novel application of heparin-binding epidermal growth factor-like growth factor for medical purposes
JP2007223939A (ja) * 2006-02-22 2007-09-06 Kobe Univ エネルギー代謝促進因子としてのｈｂ−ｅｇｆの使用
JPWO2020158690A1 (ja) * 2019-01-28 2021-12-16 東レ株式会社 肝細胞増殖因子又はその活性断片のポリエチレングリコール修飾体
AU2022230492A1 (en) * 2021-03-03 2023-10-19 Kagoshima University Hb-egf gene therapy for diabetes

Similar Documents

Publication Publication Date Title
Van Adel et al. Delivery of ciliary neurotrophic factor via lentiviral-mediated transfer protects axotomized retinal ganglion cells for an extended period of time
Kupatt et al. Cotransfection of vascular endothelial growth factor-A and platelet-derived growth factor-B via recombinant adeno-associated virus resolves chronic ischemic malperfusion: role of vessel maturation
US20080254109A1 (en) Localized myocardial injection method for treating ischemic myocardium
Liu et al. Application of recombinant adenovirus for in vivo gene delivery to spinal cord
Korecka et al. Repulsive guidance molecule a (RGMa) induces neuropathological and behavioral changes that closely resemble Parkinson's disease
JP2018527941A5 (https=)
AU2012333408B2 (en) Gene therapy for diabetic neuropathy using an HGF isoform
JP2001512142A (ja) 宿主の免疫抑制を介するａａｖベクターの再投与を可能にする方法
US20030100889A1 (en) Method of administration of a gene of interest to a vascular tissue
JP2021533801A5 (https=)
EP1132098B1 (en) Gene therapy for cerebrovascular disorders
JP2022060514A (ja) ガバペンチノイドからの干渉が減少し、ｈｇｆ異型体を発現するｄｎａコンストラクトを用いる神経病症の治療
JPWO2025211357A5 (https=)
US6641807B1 (en) Adenoviral vectors encoding erythropoietin and their use in gene therapy
JPWO2022186282A5 (https=)
Kawakami et al. Expression of hepatocyte growth factor in normal and carbon tetrachloride-treated monkeys
US12415850B2 (en) Compositions and methods for regulating production of an antibody like protein and ribonucleic acid
Acsadi et al. Interferons impair early transgene expression by adenovirus-mediated gene transfer in muscle cells
Gao et al. Intramuscular injection of an adenoviral vector expressing hepatocyte growth factor facilitates hepatic transduction with a retroviral vector in mice
CN102741277A (zh) 在治疗运动神经元疾病中的IFNγ抑制剂
WO2020238427A1 (zh) 特异杀伤肿瘤细胞的溶瘤病毒系统及其应用
JPWO2022107853A5 (https=)
Selden et al. Growth factors and the liver
Pan et al. Permeation of hepatocyte growth factor across the blood–brain barrier
Sekiguchi et al. Exogenous expression of hepatocyte growth factor (HGF) in rat striatum by naked plasmid DNA